Deal focus: Biogen’s gambit to boost neurology portfolio with Reata acquisition
Conceptual of merger or creative cooperation of two business companies. Credit: Shutterstock/Gajus Each week, Pharmaceutical Technology’s editors select a deal
Read MoreConceptual of merger or creative cooperation of two business companies. Credit: Shutterstock/Gajus Each week, Pharmaceutical Technology’s editors select a deal
Read MoreReceive free Pharmaceuticals sector updates We’ll send you a myFT Daily Digest email rounding up the latest Pharmaceuticals sector news
Read MoreFile photo. A blood sample tests positive for syphilis (Treponema Pallidum). Bigstock Doctors in the Kansas City area are seeing
Read MoreSchedule M prescribes requirements of facilities and their maintenance, personnel, manufacture, control and safety testing, storage and transport of material,
Read MoreThe West Texas Intermediate (WTI) Crude Oil market has experienced a remarkable ascent in recent weeks, but signs of hesitation
Read MoreThe typical evening shift in a city hospital on the east coast of the U.S., where “D” – originally from
Read MoreExploring the Future of Telecommunications in Pharmaceuticals: The Crucial Role of CRM Software The future of telecommunications in the pharmaceutical
Read Moreartisteer/iStock via Getty Images Amid an on-going shortage of the ADHD drug Adderall (mixed amphetamine salts), the US FDA and
Read MoreSAN FRANCISCO — As the second day of testimony in the preliminary hearing for Nima Momeni unfolded Tuesday morning, the
Read MoreUK-based industry accelerator the Cell and Gene Therapy Catapult (CGT Catapult) today announces that Jeanette Evans has been appointed chief
Read More